Global Heart Failure Diagnostics/Therapeutics Market Size, Status and Forecast 2022

October 2017 | 92 pages | ID: G38DC963972WEN
QYResearch

Abstracts

This report studies the global Heart Failure Diagnostics/Therapeutics market, analyzes and researches the Heart Failure Diagnostics/Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• Abbott Laboratories
• Beckman Coulter
• Abiomed
• Berlin Heart
• Biotronik
• Boston Scientific Corporation
• HeartWare International
• Jarvik Heart
• Medtronic
• St. Jude Medical

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, Heart Failure Diagnostics/Therapeutics can be split into

• ECG Systems
• Holter Monitors
• Event Monitors
• Implantable Loop Recorders

Market segment by Application, Heart Failure Diagnostics/Therapeutics can be split into

• Blood Tests
• Chest X-Ray
• Electrocardiogram (ECG)
• Echocardiogram
• Stress Test
• Cardiac Computerized Tomography (CT) Scan or Magnetic Resonance Imaging (MRI)
• Coronary Angiogram
• Myocardial Biopsy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Heart Failure Diagnostics/Therapeutics Market Size, Status and Forecast 2022

1 INDUSTRY OVERVIEW OF HEART FAILURE DIAGNOSTICS/THERAPEUTICS

1.1 Heart Failure Diagnostics/Therapeutics Market Overview
  1.1.1 Heart Failure Diagnostics/Therapeutics Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Heart Failure Diagnostics/Therapeutics Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Heart Failure Diagnostics/Therapeutics Market by Type
  1.3.1 ECG Systems
  1.3.2 Holter Monitors
  1.3.3 Event Monitors
  1.3.4 Implantable Loop Recorders
1.4 Heart Failure Diagnostics/Therapeutics Market by End Users/Application
  1.4.1 Blood Tests
  1.4.2 Chest X-Ray
  1.4.3 Electrocardiogram (ECG)
  1.4.4 Echocardiogram
  1.4.5 Stress Test
  1.4.6 Cardiac Computerized Tomography (CT) Scan or Magnetic Resonance Imaging (MRI)
  1.4.7 Coronary Angiogram
  1.4.8 Myocardial Biopsy

2 GLOBAL HEART FAILURE DIAGNOSTICS/THERAPEUTICS COMPETITION ANALYSIS BY PLAYERS

2.1 Heart Failure Diagnostics/Therapeutics Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Abbott Laboratories
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Heart Failure Diagnostics/Therapeutics Revenue (Value) (2012-2017)
  3.1.5 Recent Developments
3.2 Beckman Coulter
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Heart Failure Diagnostics/Therapeutics Revenue (Value) (2012-2017)
  3.2.5 Recent Developments
3.3 Abiomed
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Heart Failure Diagnostics/Therapeutics Revenue (Value) (2012-2017)
  3.3.5 Recent Developments
3.4 Berlin Heart
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Heart Failure Diagnostics/Therapeutics Revenue (Value) (2012-2017)
  3.4.5 Recent Developments
3.5 Biotronik
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Heart Failure Diagnostics/Therapeutics Revenue (Value) (2012-2017)
  3.5.5 Recent Developments
3.6 Boston Scientific Corporation
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Heart Failure Diagnostics/Therapeutics Revenue (Value) (2012-2017)
  3.6.5 Recent Developments
3.7 HeartWare International
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Heart Failure Diagnostics/Therapeutics Revenue (Value) (2012-2017)
  3.7.5 Recent Developments
3.8 Jarvik Heart
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Heart Failure Diagnostics/Therapeutics Revenue (Value) (2012-2017)
  3.8.5 Recent Developments
3.9 Medtronic
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Heart Failure Diagnostics/Therapeutics Revenue (Value) (2012-2017)
  3.9.5 Recent Developments
3.10 St. Jude Medical
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Heart Failure Diagnostics/Therapeutics Revenue (Value) (2012-2017)
  3.10.5 Recent Developments

4 GLOBAL HEART FAILURE DIAGNOSTICS/THERAPEUTICS MARKET SIZE BY TYPE AND APPLICATION (2012-2017)

4.1 Global Heart Failure Diagnostics/Therapeutics Market Size by Type (2012-2017)
4.2 Global Heart Failure Diagnostics/Therapeutics Market Size by Application (2012-2017)
4.3 Potential Application of Heart Failure Diagnostics/Therapeutics in Future
4.4 Top Consumer/End Users of Heart Failure Diagnostics/Therapeutics

5 UNITED STATES HEART FAILURE DIAGNOSTICS/THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Heart Failure Diagnostics/Therapeutics Market Size (2012-2017)
5.2 United States Heart Failure Diagnostics/Therapeutics Market Size and Market Share by Players (2016 and 2017)

6 EU HEART FAILURE DIAGNOSTICS/THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Heart Failure Diagnostics/Therapeutics Market Size (2012-2017)
6.2 EU Heart Failure Diagnostics/Therapeutics Market Size and Market Share by Players (2016 and 2017)

7 JAPAN HEART FAILURE DIAGNOSTICS/THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Heart Failure Diagnostics/Therapeutics Market Size (2012-2017)
7.2 Japan Heart Failure Diagnostics/Therapeutics Market Size and Market Share by Players (2016 and 2017)

8 CHINA HEART FAILURE DIAGNOSTICS/THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

8.1 China Heart Failure Diagnostics/Therapeutics Market Size (2012-2017)
8.2 China Heart Failure Diagnostics/Therapeutics Market Size and Market Share by Players (2016 and 2017)

9 INDIA HEART FAILURE DIAGNOSTICS/THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

9.1 India Heart Failure Diagnostics/Therapeutics Market Size (2012-2017)
9.2 India Heart Failure Diagnostics/Therapeutics Market Size and Market Share by Players (2016 and 2017)

10 SOUTHEAST ASIA HEART FAILURE DIAGNOSTICS/THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Heart Failure Diagnostics/Therapeutics Market Size (2012-2017)
10.2 Southeast Asia Heart Failure Diagnostics/Therapeutics Market Size and Market Share by Players (2016 and 2017)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)

11.1 Global Heart Failure Diagnostics/Therapeutics Market Size (Value) by Regions (2017-2022)
  11.1.1 United States Heart Failure Diagnostics/Therapeutics Revenue and Growth Rate (2017-2022)
  11.1.2 EU Heart Failure Diagnostics/Therapeutics Revenue and Growth Rate (2017-2022)
  11.1.3 Japan Heart Failure Diagnostics/Therapeutics Revenue and Growth Rate (2017-2022)
  11.1.4 China Heart Failure Diagnostics/Therapeutics Revenue and Growth Rate (2017-2022)
  11.1.5 India Heart Failure Diagnostics/Therapeutics Revenue and Growth Rate (2017-2022)
  11.1.6 Southeast Asia Heart Failure Diagnostics/Therapeutics Revenue and Growth Rate (2017-2022)
11.2 Global Heart Failure Diagnostics/Therapeutics Market Size (Value) by Type (2017-2022)
11.3 Global Heart Failure Diagnostics/Therapeutics Market Size by Application (2017-2022)

12 HEART FAILURE DIAGNOSTICS/THERAPEUTICS MARKET DYNAMICS

12.1 Heart Failure Diagnostics/Therapeutics Market Opportunities
12.2 Heart Failure Diagnostics/Therapeutics Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Heart Failure Diagnostics/Therapeutics Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Heart Failure Diagnostics/Therapeutics Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Heart Failure Diagnostics/Therapeutics Product Scope
Figure Global Heart Failure Diagnostics/Therapeutics Market Size (Million USD) (2012-2017)
Table Global Heart Failure Diagnostics/Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Heart Failure Diagnostics/Therapeutics Market Share by Regions in 2016
Figure United States Heart Failure Diagnostics/Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Heart Failure Diagnostics/Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Heart Failure Diagnostics/Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Heart Failure Diagnostics/Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Heart Failure Diagnostics/Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Heart Failure Diagnostics/Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Heart Failure Diagnostics/Therapeutics Market Share by Type in 2016
Figure ECG Systems Market Size (Million USD) and Growth Rate (2012-2017)
Figure Holter Monitors Market Size (Million USD) and Growth Rate (2012-2017)
Figure Event Monitors Market Size (Million USD) and Growth Rate (2012-2017)
Figure Implantable Loop Recorders Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Heart Failure Diagnostics/Therapeutics Market Share by Application in 2016
Table Key Downstream Customer in Blood Tests
Figure Heart Failure Diagnostics/Therapeutics Market Size (Million USD) and Growth Rate in Blood Tests (2012-2017)
Table Key Downstream Customer in Chest X-Ray
Figure Heart Failure Diagnostics/Therapeutics Market Size (Million USD) and Growth Rate in Chest X-Ray (2012-2017)
Table Key Downstream Customer in Electrocardiogram (ECG)
Figure Heart Failure Diagnostics/Therapeutics Market Size (Million USD) and Growth Rate in Electrocardiogram (ECG) (2012-2017)
Table Key Downstream Customer in Echocardiogram
Figure Heart Failure Diagnostics/Therapeutics Market Size (Million USD) and Growth Rate in Echocardiogram (2012-2017)
Table Key Downstream Customer in Stress Test
Figure Heart Failure Diagnostics/Therapeutics Market Size (Million USD) and Growth Rate in Stress Test (2012-2017)
Table Key Downstream Customer in Cardiac Computerized Tomography (CT) Scan or Magnetic Resonance Imaging (MRI)
Figure Heart Failure Diagnostics/Therapeutics Market Size (Million USD) and Growth Rate in Cardiac Computerized Tomography (CT) Scan or Magnetic Resonance Imaging (MRI) (2012-2017)
Table Key Downstream Customer in Coronary Angiogram
Figure Heart Failure Diagnostics/Therapeutics Market Size (Million USD) and Growth Rate in Coronary Angiogram (2012-2017)
Table Key Downstream Customer in Myocardial Biopsy
Figure Heart Failure Diagnostics/Therapeutics Market Size (Million USD) and Growth Rate in Myocardial Biopsy (2012-2017)
Table Heart Failure Diagnostics/Therapeutics Market Size (Million USD) by Players (2016 and 2017)
Figure Heart Failure Diagnostics/Therapeutics Market Size Share by Players in 2016
Figure Heart Failure Diagnostics/Therapeutics Market Size Share by Players in 2017
Table Abbott Laboratories Basic Information List
Table Heart Failure Diagnostics/Therapeutics Business Revenue (Million USD) of Abbott Laboratories (2012-2017)
Figure Abbott Laboratories Heart Failure Diagnostics/Therapeutics Business Revenue Market Share in 2016
Table Beckman Coulter Basic Information List
Table Heart Failure Diagnostics/Therapeutics Business Revenue (Million USD) of Beckman Coulter (2012-2017)
Figure Beckman Coulter Heart Failure Diagnostics/Therapeutics Business Revenue Market Share in 2016
Table Abiomed Basic Information List
Table Heart Failure Diagnostics/Therapeutics Business Revenue (Million USD) of Abiomed (2012-2017)
Figure Abiomed Heart Failure Diagnostics/Therapeutics Business Revenue Market Share in 2016
Table Berlin Heart Basic Information List
Table Heart Failure Diagnostics/Therapeutics Business Revenue (Million USD) of Berlin Heart (2012-2017)
Figure Berlin Heart Heart Failure Diagnostics/Therapeutics Business Revenue Market Share in 2016
Table Biotronik Basic Information List
Table Heart Failure Diagnostics/Therapeutics Business Revenue (Million USD) of Biotronik (2012-2017)
Figure Biotronik Heart Failure Diagnostics/Therapeutics Business Revenue Market Share in 2016
Table Boston Scientific Corporation Basic Information List
Table Heart Failure Diagnostics/Therapeutics Business Revenue (Million USD) of Boston Scientific Corporation (2012-2017)
Figure Boston Scientific Corporation Heart Failure Diagnostics/Therapeutics Business Revenue Market Share in 2016
Table HeartWare International Basic Information List
Table Heart Failure Diagnostics/Therapeutics Business Revenue (Million USD) of HeartWare International (2012-2017)
Figure HeartWare International Heart Failure Diagnostics/Therapeutics Business Revenue Market Share in 2016
Table Jarvik Heart Basic Information List
Table Heart Failure Diagnostics/Therapeutics Business Revenue (Million USD) of Jarvik Heart (2012-2017)
Figure Jarvik Heart Heart Failure Diagnostics/Therapeutics Business Revenue Market Share in 2016
Table Medtronic Basic Information List
Table Heart Failure Diagnostics/Therapeutics Business Revenue (Million USD) of Medtronic (2012-2017)
Figure Medtronic Heart Failure Diagnostics/Therapeutics Business Revenue Market Share in 2016
Table St. Jude Medical Basic Information List
Table Heart Failure Diagnostics/Therapeutics Business Revenue (Million USD) of St. Jude Medical (2012-2017)
Figure St. Jude Medical Heart Failure Diagnostics/Therapeutics Business Revenue Market Share in 2016
Table Global Heart Failure Diagnostics/Therapeutics Market Size (Million USD) by Type (2012-2017)
Figure Global Heart Failure Diagnostics/Therapeutics Market Size Share by Type in 2012
Figure Global Heart Failure Diagnostics/Therapeutics Market Size Share by Type in 2013
Figure Global Heart Failure Diagnostics/Therapeutics Market Size Share by Type in 2014
Figure Global Heart Failure Diagnostics/Therapeutics Market Size Share by Type in 2015
Figure Global Heart Failure Diagnostics/Therapeutics Market Size Share by Type in 2016
Figure Global Heart Failure Diagnostics/Therapeutics Market Size Share by Type in 2017
Table Global Heart Failure Diagnostics/Therapeutics Market Size (Million USD) by Application (2012-2017)
Figure Global Heart Failure Diagnostics/Therapeutics Market Size (Million USD) by Application in 2012
Figure Global Heart Failure Diagnostics/Therapeutics Market Size (Million USD) by Application in 2013
Figure Global Heart Failure Diagnostics/Therapeutics Market Size (Million USD) by Application in 2014
Figure Global Heart Failure Diagnostics/Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Heart Failure Diagnostics/Therapeutics Market Size (Million USD) by Application in 2016
Figure Global Heart Failure Diagnostics/Therapeutics Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Heart Failure Diagnostics/Therapeutics
Figure United States Heart Failure Diagnostics/Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Heart Failure Diagnostics/Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure United States Heart Failure Diagnostics/Therapeutics Market Size Share by Players in 2016
Figure United States Heart Failure Diagnostics/Therapeutics Market Size Share by Players in 2017
Figure EU Heart Failure Diagnostics/Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Heart Failure Diagnostics/Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure EU Heart Failure Diagnostics/Therapeutics Market Size Share by Players in 2016
Figure EU Heart Failure Diagnostics/Therapeutics Market Size Share by Players in 2017
Figure Japan Heart Failure Diagnostics/Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Heart Failure Diagnostics/Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Japan Heart Failure Diagnostics/Therapeutics Market Size Share by Players in 2016
Figure Japan Heart Failure Diagnostics/Therapeutics Market Size Share by Players in 2017
Figure China Heart Failure Diagnostics/Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Heart Failure Diagnostics/Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure China Heart Failure Diagnostics/Therapeutics Market Size Share by Players in 2016
Figure China Heart Failure Diagnostics/Therapeutics Market Size Share by Players in 2017
Figure India Heart Failure Diagnostics/Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Heart Failure Diagnostics/Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure India Heart Failure Diagnostics/Therapeutics Market Size Share by Players in 2016
Figure India Heart Failure Diagnostics/Therapeutics Market Size Share by Players in 2017
Figure Southeast Asia Heart Failure Diagnostics/Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Heart Failure Diagnostics/Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Heart Failure Diagnostics/Therapeutics Market Size Share by Players in 2016
Figure Southeast Asia Heart Failure Diagnostics/Therapeutics Market Size Share by Players in 2017
Figure Global Heart Failure Diagnostics/Therapeutics Market Size (Million USD) by Regions (2017-2022)
Table Global Heart Failure Diagnostics/Therapeutics Market Size (Million USD) by Regions (2017-2022)
Figure Global Heart Failure Diagnostics/Therapeutics Market Size Share by Regions in 2017
Figure Global Heart Failure Diagnostics/Therapeutics Market Size Share by Regions in 2022
Figure United States Heart Failure Diagnostics/Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Heart Failure Diagnostics/Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Heart Failure Diagnostics/Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Heart Failure Diagnostics/Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Heart Failure Diagnostics/Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Heart Failure Diagnostics/Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Heart Failure Diagnostics/Therapeutics Market Size (Million USD) by Type (2017-2022)
Figure Global Heart Failure Diagnostics/Therapeutics Market Size Share by Type in 2017
Figure Global Heart Failure Diagnostics/Therapeutics Market Size Share by Type in 2022
Table Global Heart Failure Diagnostics/Therapeutics Market Size (Million USD) by Application (2017-2022)
Figure Global Heart Failure Diagnostics/Therapeutics Market Size (Million USD) by Application in 2017
Figure Global Heart Failure Diagnostics/Therapeutics Market Size (Million USD) by Application in 2022